Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669451 | 12566945 | 1 | I | 20151201 | 20160707 | 20160718 | 20160718 | EXP | GB-MHRA-EYC 00141824 | PHHY2016GB094211 | SANDOZ | 34.00 | YR | M | Y | 80.00000 | KG | 20160718 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669451 | 12566945 | 1 | PS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Oral | TAPERED FROM 40MG TO ZERO IN SIX WEEKS | 75566 | 40 | MG | ||||||||
| 125669451 | 12566945 | 2 | C | CYCLIZINE HYDROCHLORIDE | CYCLIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 3 | C | FORTISIP | CARBOHYDRATESFATTY ACIDSMINERALSPROTEINVITAMINS | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 4 | C | GAVISCON ADVANCE | POTASSIUM BICARBONATESODIUM ALGINATE | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 6 | C | HYDROXYTRYPTOPHAN | OXITRIPTAN | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 8 | C | OMEGA 3 FISH OIL//FISH OIL | 2 | Unknown | U | 0 | |||||||||||
| 125669451 | 12566945 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 10 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 11 | C | VITAMIN B COMPLEX /00003501/ | 2 | Unknown | U | 0 | |||||||||||
| 125669451 | 12566945 | 12 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 125669451 | 12566945 | 13 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125669451 | 12566945 | 1 | Depression |
| 125669451 | 12566945 | 2 | Nausea |
| 125669451 | 12566945 | 3 | Product used for unknown indication |
| 125669451 | 12566945 | 4 | Product used for unknown indication |
| 125669451 | 12566945 | 5 | Product used for unknown indication |
| 125669451 | 12566945 | 6 | Product used for unknown indication |
| 125669451 | 12566945 | 7 | Product used for unknown indication |
| 125669451 | 12566945 | 8 | Product used for unknown indication |
| 125669451 | 12566945 | 9 | Product used for unknown indication |
| 125669451 | 12566945 | 10 | Product used for unknown indication |
| 125669451 | 12566945 | 11 | Product used for unknown indication |
| 125669451 | 12566945 | 12 | Product used for unknown indication |
| 125669451 | 12566945 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125669451 | 12566945 | LT |
| 125669451 | 12566945 | OT |
| 125669451 | 12566945 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125669451 | 12566945 | Agitation | |
| 125669451 | 12566945 | Anger | |
| 125669451 | 12566945 | Anxiety | |
| 125669451 | 12566945 | Back pain | |
| 125669451 | 12566945 | Chest pain | |
| 125669451 | 12566945 | Chills | |
| 125669451 | 12566945 | Condition aggravated | |
| 125669451 | 12566945 | Decreased appetite | |
| 125669451 | 12566945 | Depression | |
| 125669451 | 12566945 | Dizziness | |
| 125669451 | 12566945 | Dyschromatopsia | |
| 125669451 | 12566945 | Dyskinesia | |
| 125669451 | 12566945 | Hyperacusis | |
| 125669451 | 12566945 | Hyperhidrosis | |
| 125669451 | 12566945 | Hypersensitivity | |
| 125669451 | 12566945 | Hypervigilance | |
| 125669451 | 12566945 | Hypoaesthesia | |
| 125669451 | 12566945 | Insomnia | |
| 125669451 | 12566945 | Mood swings | |
| 125669451 | 12566945 | Palpitations | |
| 125669451 | 12566945 | Peripheral coldness | |
| 125669451 | 12566945 | Photophobia | |
| 125669451 | 12566945 | Rash | |
| 125669451 | 12566945 | Salivary hypersecretion | |
| 125669451 | 12566945 | Suicidal ideation | |
| 125669451 | 12566945 | Thirst | |
| 125669451 | 12566945 | Vertigo | |
| 125669451 | 12566945 | Visual impairment | |
| 125669451 | 12566945 | Vomiting | |
| 125669451 | 12566945 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125669451 | 12566945 | 1 | 19981201 | 20151201 | 0 |